Australia Drug Screening Market Size & Outlook, 2026-2033
The drug screening market in Australia is expected to reach a projected revenue of US$ 368.6 million by 2033. A compound annual growth rate of 8% is expected of Australia drug screening market from 2026 to 2033.
Revenue, 2025 (US$M)
$200.0
Estimate, 2026 (US$M)
$214.8
Forecast, 2033 (US$M)
$368.6
CAGR, 2026 - 2033
8.0%
Global Market
Related Markets
Australia drug screening market highlights
- The Australia drug screening market generated a revenue of USD 200.0 million in 2025 and is expected to reach USD 368.6 million by 2033.
- The Australia market is expected to grow at a CAGR of 8% from 2026 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2025.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Drug screening market data book summary
| Market revenue in 2025 | USD 200.0 million |
| Market revenue in 2033 | USD 368.6 million |
| Growth rate | 8% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services & Others, Instruments, Rapid Testing Devices, Consumables |
| Key market players worldwide | Abbott Laboratories, Quest Diagnostics Inc, Roche Holding AG, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Labcorp Holdings Inc, OraSure Technologies Inc, Omega Laboratories, Draegerwerk AG & Co KGaA, Bio-Rad Laboratories Inc Class A |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global drug screening market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China drug screening market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 626.8 million by 2033.
No credit card required*
Publish Date: Jul 08, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Drug Screening Market Scope
Drug Screening Market segmentation & scope
Others
Drug Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Draegerwerk AG & Co KGaA | View profile | 16,476 | Moislinger Allee 53–55, Lubeck, Germany, 23542 | www.draeger.com |
| Omega Laboratories | View profile | 101-250 | Mogadore, Ohio, United States, North America | www.omegalaboratories.com/ |
| OraSure Technologies Inc | View profile | 638 | 220 East First Street, Bethlehem, PA, United States, 18015 | www.orasure.com |
| Bio-Rad Laboratories Inc Class A | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
Australia Drug Screening Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Screening Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 37.6% in 2025.
Horizon Databook has segmented the Australia drug screening market based on services & others, instruments, rapid testing devices, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
- Australia Drug Screening Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Rapid Testing Devices
- Consumables
- Services & Others
- Australia Drug Screening Market Sample Outlook (Revenue, USD Million , 2021-2033)
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
- Australia Drug Screening Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Criminal Justice & Law Enforcement Agencies
- Workplaces
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools & Colleges
- Others
Reasons to subscribe to Drug Screening Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Screening Market Outlook databook
- Our clientele includes a mix of Drug Screening Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Drug Screening Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Drug Screening Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Drug Screening Market, 2021-2033 (US$M)
Australia Product - Drug Screening Market Statistics, 2025 - 2033 (US$M)
